Stelmakh Edward 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Stelmakh Edward（CIK 1887046）在 1 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-08-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-24 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 卖出 | 1,381 | $10,648 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 买入 | 5,237 | $0 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 卖出 | 1,388 | $18,752 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 卖出 | 3,658 | $46,603 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 卖出 | 1,388 | $18,752 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 买入 | 5,237 | $0 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 买入 | 16,623 | $0 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Finance & Strat Officer | 卖出 | 4,406 | $82,612 |
| 2025-08-25 | OptimizeRx Corp (OPRX) | CFO/COO | 买入 | 15,625 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-24